Oneindig Technologies
- Issue price
- ₹ 96
- Issue size
- ₹ 27.65 Cr.
- Min. investment
- ₹ 1,15,200
- Listing price
- ₹ 120
- Subscribed
- 1.68x
- Lot size
- 1,200 shares
- P/E
- 14.18
- RoNW
- 37.58%
- RoCE
- 30.31%
- EPS
- ₹ 6.77
- Promoter stake
- 37.8%
Timeline
- doneOpens30 Jul
- doneCloses3 Aug
- doneAllotment4 Aug
- doneListing6 Aug
Grey market premium (GMP)
GMP is an unofficial premium from the unregulated grey market. It is not published, verified or regulated by SEBI, NSE or BSE, grey market deals are not legally enforceable, and it is not a reliable indicator of the listing price. Do not apply for an IPO on the basis of GMP. It is not a recommendation of Minerva Capital Research Solutions.
- Highest
- ₹ 7 on 5 Aug 2026
- Lowest
- ₹ 0 on 27 Jul 2026
- First quoted
- ₹ 0 on 27 Jul 2026
Subscription
How many times each investor group bid for its share, as of 08 Aug 2026, 03:10 PM IST.
How much to apply for
The smallest and largest bids for each kind of investor at the upper price band.
| Retail (Min) | 1 | 1,200 | ₹ 1,15,200 |
| Retail (Max) | 1 | 1,200 | ₹ 1,15,200 |
| HNI (Min) | 2 | 2,400 | ₹ 2,30,400 |
Company overview
Financials
| Assets | 88.99 | 35.53 |
| Total Income | 57.56 | 46.14 |
| Profit After Tax | 6.16 | 4.17 |
| EBITDA | 10.52 | 6.87 |
| NET Worth | 20.65 | 14.68 |
| Reserves and Surplus | 12.61 | 6.64 |
| Total Borrowing | 50.77 | 6.96 |
What the money is for
| To meet working capital requirements | 20 |
| General Corporate Purposes | 3.99 |
| Issue Expenses | 3.66 |
Promoters
- Manoj Agarwal
- Seema Agarwal
Registrar, lead managers and documents
- Listing on
- BSE SME
- Face value
- ₹ 10 a share
- Registrar
- Maashitla Securities Private Limited
- Lead managers
- Share India Capital Services Private Limited
IPO dates, prices, grey market premium (GMP), subscription and the company overview: IPO Guru, updated three times a day. GMP is an unofficial premium from the unregulated grey market. It is not published, verified or regulated by SEBI, NSE or BSE, grey market deals are not legally enforceable, and it is not a reliable indicator of the listing price. Do not apply for an IPO on the basis of GMP. It is not a recommendation of Minerva Capital Research Solutions.
Our recommendations are research opinions, not investment advice. Read the offer document (RHP) and consult your financial adviser before investing.